Company & Sponsor Intelligence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed0
Countries1
Therapeutic footprint
anxietyother_neurologypain_neuropathyparkinsons
Indexed studies
NCT06001489The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy
anxiety · NetherlandsNA
anxiety · NetherlandsNA
NCT05832034Add-on Intravenous Immunoglobulins in Early Myositis
other_neurology · NetherlandsPHASE2, PHASE3
other_neurology · NetherlandsPHASE2, PHASE3
NCT06223399DBS Imaging-based vs. Threshold Assessment-based Programming
parkinsons · NetherlandsNA
parkinsons · NetherlandsNA
NCT05735756Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain
pain_neuropathy · NetherlandsPHASE4
pain_neuropathy · NetherlandsPHASE4
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →